|
Authorized Generic Deals May Be a Thing of the Past, Lawyer Says
Drug companies’ patent settlements may no longer need clauses preventing authorized generic (AG) launches after last month’s landmark court decision on pay-for-delay deals, a pharma lawyer says.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives